Astrana Health EPS - Earnings per Share 2016-2026 | ASTH
Astrana Health eps - earnings per share from 2016 to 2026. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Astrana Health Annual EPS | |
|---|---|
| 2025 | $0.46 |
| 2024 | $0.90 |
| 2023 | $1.29 |
| 2022 | $0.99 |
| 2021 | $1.52 |
| 2020 | $1.01 |
| 2019 | $0.39 |
| 2018 | $0.29 |
| 2017 | $0.90 |
| 2017 | $-1.49 |
| 2016 | $0.41 |
| 2016 | $-1.79 |
| 2015 | $0.00 |
| 2015 | $-0.37 |
| 2014 | $0.00 |
| Astrana Health Quarterly EPS | |
|---|---|
| 2026-06-30 | $0.40 |
| 2026-03-31 | $0.29 |
| 2025-12-31 | $0.12 |
| 2025-09-30 | $0.01 |
| 2025-06-30 | $0.19 |
| 2025-03-31 | $0.14 |
| 2024-12-31 | $-0.14 |
| 2024-09-30 | $0.33 |
| 2024-06-30 | $0.40 |
| 2024-03-31 | $0.31 |
| 2023-12-31 | $0.26 |
| 2023-09-30 | $0.47 |
| 2023-06-30 | $0.28 |
| 2023-03-31 | $0.28 |
| 2022-12-31 | $-0.07 |
| 2022-09-30 | $0.50 |
| 2022-06-30 | $0.26 |
| 2022-03-31 | $0.30 |
| 2021-12-31 | $0.20 |
| 2021-09-30 | $0.74 |
| 2021-06-30 | $0.28 |
| 2021-03-31 | $0.30 |
| 2020-12-31 | $0.26 |
| 2020-09-30 | $0.45 |
| 2020-06-30 | $0.19 |
| 2020-03-31 | $0.11 |
| 2019-12-31 | $0.20 |
| 2019-09-30 | $0.10 |
| 2019-06-30 | $0.09 |
| 2019-03-31 | $0.00 |
| 2018-12-31 | $-0.08 |
| 2018-09-30 | $0.24 |
| 2018-06-30 | $0.07 |
| 2018-03-31 | $0.06 |
| 2017-12-31 | $0.48 |
| 2017-09-30 | $0.20 |
| 2017-06-30 | $0.07 |
| 2017-03-31 | $0.15 |
| 2016-12-31 | $0.00 |
| 2016-03-31 | $0.00 |
| 2015-03-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.138B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |